Drugs for Tendinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 157)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Polidocanol |
Approved |
Phase 4 |
|
9002-92-0 |
|
Synonyms:
Aethoxy-sklerol
Laureth 9
Laureth-9
Macrogol 9 lauryl ether
Nonaethylene glycol monododecyl ether
|
Nonaethylene glycol monolauryl ether
PEG-9 lauryl ether
Polydocanol
Polyethylene glycol 450 lauryl ether
Polyoxyl 9 lauryl ether
|
|
2 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5 |
3033 |
Synonyms:
(2,6-Dichlorophenyl)amino]benzeneacetic acid
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-dichloroanilino)phenyl]acetic acid
[2-(2,6-Dichloroanilino)phenyl]acetic acid
[o-(2,6-Dichloroanilino)phenyl]acetic acid
{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
15307-81-0 (mono-potassium salt)
15307-86-5
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-dichlorophenyl)amino)benzeneacetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-(2,6-Dichloroanilino)phenylacetic Acid
2-(2,6-Dichlorophenylamino)phenylacetic acid
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid
2-[2-(2,6-dichloroanilino)phenyl]acetic acid
2-[2-(2,6-Dichlorophenylamino)phenyl]acetic acid
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
2b17
AC1L1F0T
Acetic acid, [o-(2,6-dichloroanilino)phenyl]- (8CI)
AKOS001579542
Allvoran
Apo-Diclo
Assaren
Benfofen
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)- (9CI)
BIDD:GT0380
BPBio1_000516
BRD-K08252256-236-05-6
BRN 2146636
BSPBio_000468
BSPBio_002169
C01690
Cataflam
CHEBI:47381
CHEMBL139
CID3033
cMAP_000014
D07816
D30801
D3748
DB00586
Delphimix
dichlofenac
Dichlofenac
Dichlofenal
Dichronic
Diclac
Diclobenin
diclofenac
Diclofenac
Diclofenac (INN)
Diclofenac [INN:BAN]
Diclofenac acid
Diclofenac Acid
Diclofenac potassium
Diclofenac Potassium
Diclofenac sodium
Diclofenac Sodium
Diclofenac, sodium
Diclofenaco
Diclofenaco [INN-Spanish]
Diclofenacum
Diclofenacum [INN-Latin]
Diclofenamate
Diclofenamic acid
Diclomelan
Diclonate p
Diclonate P
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
Dicloreuma
Dicrofenac
DIF
DivK1c_000272
DivK1c_000402
Dolobasan
Duravolten
Dyloject
Ecofenac
Effekton
|
EINECS 239-348-5
Feloran
GP-45,840
henyl)-o-aminophenylacetic acid
HMS2090C10
HMS501E04
HSDB 7234
I14-7739
IDI1_000272
IDI1_000402
ISV-205
KBio1_000272
KBio1_000402
KBio2_001410
KBio2_002306
KBio2_003978
KBio2_004874
KBio2_006546
KBio2_007442
KBio3_001389
KBio3_002786
KBioGR_001051
KBioGR_002306
KBioSS_001410
KBioSS_002308
Kriplex
Lopac0_000441
LS-11575
MolPort-000-003-072
N-(2,6-Dichlorop
NCGC00021125-01
Neriodin
NINDS_000272
NINDS_000402
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Oprea1_011155
Orthofen
Orthophen
Ortofen
Pennsaid
Prestwick0_000594
Prestwick1_000594
Prestwick2_000594
Prestwick3_000594
Primofenac
Prophenatin
ProSorb-D
Rhumalgan
SBB068617
Sodium diclofenac
Solaraze
Solaraze (TN)
Solaraze T
SPBio_001081
SPBio_002687
Spectrum_000930
Spectrum2_000991
Spectrum3_000385
Spectrum4_000506
Spectrum5_000867
SR 38
SR-38
STK984493
Transfenac
Tsudohmin
UNII-144O8QL0L1
UNM000001216103
Valetan
Voldal
Voltaflan
Voltaren
Voltaren Ophtha
Voltaren ophthalmic
Voltaren Ophthalmic
Voltaren Rapide
Voltaren SR
Voltaren-XR
Voltarol
Xenid
Zorvolex
|
|
3 |
|
Etoricoxib |
Approved, Investigational |
Phase 4 |
|
202409-33-4 |
123619 |
Synonyms:
202409-33-4
5CH
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-3-(4-methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulphonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
AC1L3WZM
Algix
Arcoxia
C11718
C422649
CHEBI:106706
CHEBI:6339
CHEMBL416146
CID123619
D03710
DB01628
DB07166
|
Etoricoxib
étoricoxib
Etoricoxib (USAN/INN)
Etoricoxib [USAN:INN:BAN]
Etoricoxibe
Etoricoxibum
FT-0082494
HMS2090A05
L001141
L791456
L-791456
LS-181802
Merck Sharp & Dohme brand of etoricoxib
MK 0663
MK 663
MK-0663
MK-663
MolPort-003-847-339
NCGC00164578-01
Nucoxia
Tauxib
UNII-WRX4NFY03R
ZINC00579472
|
|
4 |
|
Etanercept |
Approved, Investigational |
Phase 4 |
|
185243-69-0 |
|
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
etanercept
Etanercept
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
Etanercept (USAN/INN)
etanercept-szzs
|
etanercept-ykro
p75
p80 TNF-alpha receptor
Recombinant human TNF
rhu TNFR:Fc
rhu-TNFR:Fc
TNF-R2
TNFR-Immunoadhesin
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
|
|
5 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4 |
|
9004-61-9 |
53477741 |
Synonyms:
(2S,3S,4R,5R,6R)-3-{[(2S,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,6-trihydroxyoxane-2-carboxylate
Hyaluronan
|
|
|
6 |
|
Mannitol |
Approved, Investigational |
Phase 4 |
|
69-65-8 |
453 6251 |
Synonyms:
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
Ambap69-65-8
AR-1J3861
bmse000099
BRN 1721898
Bronchitol
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
cpd without stereochemical designation
D-(-)-Mannitol
D00062
D008353
Diosmol
DL-Mannitol
D-mannite
D-mannitol
D-Mannitol
D-Mannitol (JP15)
Dulcite
e 421
e421
e-421
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Hexahydroxyhexane
Hexanhexol
HSDB 714
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
|
M9546_SIAL
M9647_SIAL
Manicol
manita
Manitol
Maniton S
Maniton-S
Manna sugar
Manna Sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
mannitol
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol [USAN]
Mannitol 10%
Mannitol 10% In Plastic Container
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
Mannitol 15%
Mannitol 15% In Plastic Container
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
Mannitol 20%
Mannitol 20% In Plastic Container
MANNITOL 25%
Mannitol 5%
Mannitol 5% In Plastic Container
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
Mannitolum
Mannogem 2080
Marine crystal
Marine Crystal
MLS001335977
MLS001335978
MolPort-003-927-039
MTL
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Osmitrol 15% In Water
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
Osmitrol 20% In Water
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Osmitrol 5% In Water
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
Sorbitol-Mannitol
SORBITOL-MANNITOL IN PLASTIC CONTAINER
TL806434
Tobrex
UNII-3OWL53L36A
ZINC02041302
|
|
7 |
|
Betamethasone |
Approved, Vet_approved |
Phase 4 |
|
378-44-9 |
9782 |
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16b-Methyl-1,4-pregnadiene-9a-fluoro-11b,17a,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
16Β-methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9.alpha.-Fluoro-16.beta.-methylprednisolone
9a-Fluoro-16b-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16b-methylprednisolone
9-Fluoro-16β-methylprednisolone
9α-Fluoro-16β-methylprednisolone
9Α-fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
betamethasone
beta-Methasone
Betamethasone
Bétaméthasone
Betamethasone (JP15/USP/INN)
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
beta-Methasone alcohol
Betamethasone alcohol
Betamethasone Base
Betamethasone cream
Betamethasone Valearate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
Betsolan
BIDD:PXR0047
|
b-Methasone alcohol
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
C22H29FO5
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
CHEBI:3077
CHEMBL632
CID3003
CID9782
Cidoten
CPD000339803
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
Hormezon
HSDB 3015
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
Methazon
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
MLS-0310139.0001
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC39470
NSC-39470
Prestwick_703
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
Î’-methasone alcohol
|
|
8 |
|
Guanfacine |
Approved, Investigational |
Phase 4 |
|
29110-47-2 |
3519 |
Synonyms:
29110-47-2
29110-48-3 (mono-hydrochloride)
AC1L1G4B
BPBio1_000415
BRD-K32830106-003-03-0
BSPBio_000377
C07037
C9H9Cl2N3O
CAS-29110-48-3
CHEMBL862
CID3519
D08031
DB01018
EINECS 249-442-8
Estulic
Estulic (TN)
G1043_SIGMA
Guanfacina
Guanfacina [INN-Spanish]
Guanfacine
GUANFACINE
Guanfacine (INN)
Guanfacine [INN:BAN]
Guanfacine hydrochloride
Guanfacine monohydrochloride
Guanfacine Monohydrochloride
Guanfacinum
Guanfacinum [INN-Latin]
|
Hydrochloride, guanfacine
Intuniv
L000286
L013430
Lon798
Lopac0_000519
Lopac-G-1043
LS-174236
MolPort-003-941-447
Monohydrochloride, guanfacine
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide
NCGC00015469-01
NCGC00015469-02
NCGC00015469-06
NCGC00024950-01
NCGC00024950-02
NCGC00024950-03
Prestwick0_000339
Prestwick1_000339
Prestwick2_000339
Prestwick3_000339
SPBio_002298
SPD 503
Tenex
Tocris-1030
UNII-30OMY4G3MK
ZINC03872738
|
|
9 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
38396-39-3, 2180-92-9 |
2474 |
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(±)-bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
15233-43-9
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
2180-92-9
38396-39-3
AB00053674
Abbott brand OF bupivacaine hydrochloride
AC1L1DRE
AC1Q5LX4
AC-2096
AH 250
AKOS001637202
Anekain
Anhydrous, bupivacaine
AR-1A0242
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bio-0886
Bloqueina
BPBio1_000298
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bucaine
Bucaine (TN)
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
bupivacaine
Bupivacaine
Bupivacaine (INN)
Bupivacaine [INN:BAN]
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine HCL KIT
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacaine Monohydrochloride, Monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
C07529
C18H28N2O
Carbonate, bupivacaine
Carbostesin
cBupivacaine
CBupivacaine
CHEBI:3215
CHEMBL1098
|
CID2474
D07552
DB00297
DepoBupivacaine
DivK1c_000758
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
Dolanaest
DUR-843
EINECS 218-553-3
EINECS 253-911-2
Exparel
HMS2090F12
Hydrochloride, bupivacaine
IDI1_000758
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MLS001361336
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Pisa brand OF bupivacaine hydrochloride
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SMR000058218
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
|
|
10 |
|
Cortisone |
Experimental |
Phase 4 |
|
53-06-5 |
222786 |
Synonyms:
11-dehydro-17-hydroxycorticosterone
11-Dehydro-17-hydroxycorticosterone
17a,21-Dihydroxy-4-pregnene-3,11,20-trione
17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione
17-Hydroxy-11-dehydrocorticosterone
17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
17α,21-dihydroxy-4-pregnene-3,11,20-trione
17Α,21-dihydroxy-4-pregnene-3,11,20-trione
4-Pregnene-17a,21-diol-3,11,20-trione
4-Pregnene-17alpha,21-diol-3,11,20-trione
4-pregnene-17α,21-diol-3,11,20-trione
4-Pregnene-17α,21-diol-3,11,20-trione
Adreson
Andreson
Anusol HC
Balneol-HC
beta-HC
Colocort
Compound e
Corlin
Cortadren
Cortandren
Cortef
Cortef acetate
Cortisal
Cortisate
Cortison
Cortisona
Cortisone acetate
Cortisonum
Cortistal
Cortivite
Cortogen
Cortone
Cortone acetate
Cortril
delta(4)-Pregnene-17a,21-diol-3,11,20-trione
|
Delta(4)-Pregnene-17alpha,21-diol-3,11,20-trione
Dermacort
Dricort
Flexicort
Florinef
Fludrocortisone acetate
Glycort
Hemsol-HC
Hi-cor
Incortin
Kendall'S compound
Kendall's compound e
Kendall's compound E
Kortison
Locoid
Locoid lipocream
Micort-HC
Nogenic HC
Orabase hca
Pandel
Pregn-4-en-17a,21-diol-3,11,20-trione
Pregn-4-en-17alpha,21-diol-3,11,20-trione
pregn-4-en-17α,21-diol-3,11,20-trione
Pregn-4-en-17α,21-diol-3,11,20-trione
Prestwick_132
Reichstein fa
Reichstein's substance fa
Reichstein's substance Fa
Scheroson
Solu-cortef
Stie-cort
Texacort
Westcort
Wintersteiner's compound F
Δ(4)-pregnene-17a,21-diol-3,11,20-trione
Δ(4)-pregnene-17α,21-diol-3,11,20-trione
|
|
11 |
|
Protective Agents |
|
Phase 4 |
|
|
|
12 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
13 |
|
Sclerosing Solutions |
|
Phase 4 |
|
|
|
14 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Viscosupplements |
|
Phase 4 |
|
|
|
16 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
17 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
18 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
19 |
|
Ibuprofen |
Approved |
Phase 3 |
|
15687-27-1 |
3672 |
Synonyms:
(+-)-2-(p-Isobutylphenyl)propionate
(+-)-2-(p-Isobutylphenyl)propionic acid
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-Ibuprofen
(+-)-p-Isobutylhydratropate
(+-)-p-Isobutylhydratropic acid
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetate
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetic acid
(±)-2-(p-isobutylphenyl)propionic acid
(±)-ibuprofen
(±)-p-isobutylhydratropic acid
(±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid
(4-Isobutylphenyl)-alpha-methylacetate
(4-Isobutylphenyl)-alpha-methylacetic acid
(4-Isobutylphenyl)-a-methylacetate
(4-Isobutylphenyl)-a-methylacetic acid
(4-Isobutylphenyl)-α-methylacetate
(4-isobutylphenyl)-α-methylacetic acid
(4-Isobutylphenyl)-α-methylacetic acid
(RS)-ibuprofen
(RS)-Ibuprofen
139466-08-3
15687-27-1
2-(4-Isobutylphenyl)propanoate
2-(4-isobutylphenyl)propanoic acid
2-(4-Isobutylphenyl)propanoic acid
4-Isobutylhydratropate
4-isobutylhydratropic acid
4-Isobutylhydratropic acid
58560-75-1
a-(4-Isobutylphenyl)propionate
a-(4-Isobutylphenyl)propionic acid
a-(p-Isobutylphenyl)propionate
a-(p-Isobutylphenyl)propionic acid
AC-11312
AC1L1GGE
AC1Q1P84
AC1Q1P85
ACHES-N-PAIN
Act-3
Actiprofen
Adex 200
Adran
Advil
Advil (TN)
Advil Liqui-Gels
Ak+C2278tren
Alaxan
Algofen
alpha-(4-Isobutylphenyl)propionate
alpha-(4-Isobutylphenyl)propionic acid
alpha-(p-Isobutylphenyl)propionate
alpha-(p-Isobutylphenyl)propionic acid
alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
alpha-p-Isobutylphenylpropionate
alpha-p-Isobutylphenylpropionic acid
Aluminum salt ibuprofen
Amelior
Amersol
Am-Fam 400
Amibufen
Anafen
Anco
Andran
Anflagen
Antagil
Antalfene
Antarene
Antiflam
Apo-Ibuprofen
Apsifen
Apsifen-F
ARONIS23835
Artofen
Artril
Artril 300
Balkaprofen
BB_SC-1358
Betaprofen
BIDD:GT0050
Bloom
Bluton
BRN 2049713
Brofen
Brufanic
Brufen
Brufen 400
Bruflam
Brufort
Buburone
Bufeno
Bufigen
Bukrefen
Bupron
Buracaps
Burana
Butylenin
C01588
C13H18O2
Calcium salt ibuprofen
Cap-Profen
Carol
CCRIS 3223
Cesra
CHEBI:5855
CHEMBL521
Children's Advil
Children's Elixsure
Children's Ibuprofen
Children's Motrin
CID3672
Citalgan
Cobo
Codral
Combiflam
CPD000058184
Cunil
D00126
D007052
Daiprophen
Dalsy
Dansida
DB01050
Deep Relief
Dentigoa
Dibufen
Dignoflex
Dolgin
Dolgirid
Dolgit
Dolibu
Dolmaral
DOLO PUREN
Dolocyl
Dolo-dolgit
Dolo-Dolgit
Dolofen
Dolofen-F
Dolofin
Dolofort
Dologel
Dolomax
Doloren
Dolormin
Doltibil
Dolven
Donjust B
Dorival
Drin
Duafen
Duobrus
Dura-Ibu
Duralbuprofen
Dysdolen
Easifon
Ebufac
Emflam
Emflam-200
Emodin
Epobron
Eputex
Ergix
Esprenit
EU-0100691
Exneural
Faspic
Femadon
Femafen
Femapirin
Femidol
Fenbid
Fenbid Spansule
Fendol
Fenspan
Fibraflex
Gelufene
Gofen
Grefen
Gynofug
Haltran
HMS1920F15
HMS2089P05
HMS2091N03
HMS502M09
HSDB 3099
I 4883
I.V. solution, ibuprofen
I01-7039
I0415
I4883_SIGMA
I7905_SIAL
IB-100
Ibol
Ibren
Ibu
Ibu-attritin
Ibu-Attritin
Ibubest
Ibubeta
Ibucasen
Ibudol
Ibudolor
Ibufen
Ibuflamar
Ibufug
|
Ibugel
Ibugen
Ibugesic
Ibuhexal
Ibulagic
Ibular
Ibulav
Ibuleve
Ibulgan
Ibumed
Ibumerck
Ibumetin
Ibupirac
Ibuprin
Ibuprocin
ibuprofen
Ibuprofen
Ibuprofen i.v. solution
Ibuprofen zinc
Ibuprofen, (+-)-isomer
Ibuprofen, (R)-isomer
Ibuprofen, (S)-isomer
Ibuprofen, aluminum salt
Ibuprofen, calcium salt
Ibuprofen, copper (2+) salt
Ibuprofen, magnesium salt
Ibuprofen, potassium salt
Ibuprofen, sodium salt
Ibuprofen, zinc salt
Ibuprofene
Ibuprofeno
Ibuprofenum
Ibuprofen-zinc
Ibuprohm
Ibuprophen
Ibusal
Ibu-slo
Ibu-Slo
Ibu-slow
Ibu-Tab
Ibu-Tab 200
Ibutid
IDI1_000887
Ifen
Inabrin
Inflam
Inoven
IP 82
IP82
IP-82
Ipren
Irfen
Isodol
Jenaprofen
Junifen
Junior Strength Advil
Junior Strength Ibuprofen
Junior Strength Motrin
KBio1_000887
KBio2_001329
KBio2_003897
KBio2_006465
KBio3_001390
Kesan
Kratalgin
Lamidon
Lebrufen
Librofem
Lidifen
Liptan
Lopane
LS-7454
Magnesium salt ibuprofen
Malafene
Manypren
Medipren
Melfen
Mensoton
Midol
Midol 200
MLS000069733
MLS001146965
Moment
Motrin
Motrin (TN)
Motrin IB
Mynosedin
Nagifen-D
Napacetin
Narfen
NCI60_002065
Neobrufen
Neo-Helvagit
Neo-Mindol
NeoProfen
Nerofen
NINDS_000887
Noalgil
Nobafon
Nobfelon
Nobfen
Nobgen
Noritis
Norton
Novadol
Novogent
Novogent N
Novoprofen
Novo-Profen
NSC 256857
NSC256857
Nuprilan
Nuprin
Nurofen
Optifen
Opturem
Oralfene
Ostarin
Ostofen
Ozonol
Paduden
Panafen
Pantrop
Para-Isobutylhydratropic Acid
Paxofen
Pediaprofen
PediaProfen
Pedia-Profen
Pediatric Advil
Perofen
p-Isobutyl-2-phenylpropionate
p-Isobutyl-2-phenylpropionic acid
p-Isobutylhydratropate
p-Isobutylhydratropic acid
P-Isobutylhydratropic Acid
Potassium salt ibuprofen
Proartinal
Profen
Proflex
Provon
Quadrax
R.D. 13621
Rafen
Ranofen
RD 13621
Rebugen
Relcofen
Rhinadvil
Rofen
Roidenin
Rufen
Rufin
Rupan
Sadefen
Salivia
Salprofen
Salt ibuprofen, magnesium
Salt ibuprofen, sodium
Salt ibuprofen, zinc
SAM002264619
Seclodin
Sednafen
Seklodin
Seskafen
Siyafen
SMR000058184
Sodium salt ibuprofen
Solpaflex
Solufen
SPBio_000178
Stelar
STK177358
Sugafen
Suprafen
Suspren
Syntofene
Tabalon
Tabalon 400
Tab-Profen
Tatanal
Tempil
TL8001184
Tofen
Togal N
Tonal
Trauma dolgit gel
Trauma-dolgit gel
TraumaDolgit gel
Trendar
U 18573
U-18,573
U-18573
UCB 79171
Unipron
Upfen
Uprofen
Urem
VUFB 9649
Zafen
Zinc salt ibuprofen
Zofen
Α-(4-isobutylphenyl)propionate
α-(4-isobutylphenyl)propionic acid
Α-(4-isobutylphenyl)propionic acid
Α-(p-isobutylphenyl)propionate
α-(p-isobutylphenyl)propionic acid
Α-(p-isobutylphenyl)propionic acid
|
|
20 |
|
Copper |
Approved, Investigational |
Phase 3 |
|
7440-50-8 |
27099 |
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
21 |
|
Selenium |
Approved, Investigational, Vet_approved |
Phase 3 |
|
7782-49-2 |
|
Synonyms:
Se(2+)
Se2+
Selanediide
Selen
Selenide
Selenide(2-)
Selenio
|
Sélénium
Selenium dication
Selenium elemental
Selenium ion (se2+)
Selenium metallicum
Selenium, elemental
|
|
22 |
|
Zinc |
Approved, Investigational |
Phase 3 |
|
7440-66-6 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
23 |
|
Ropivacaine |
Approved |
Phase 2, Phase 3 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-pipecoloxylidide
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
|
L-N-n-propylpipecolic acid-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
LS-113954
MLS001401363
MolPort-003-983-292
Naropeine
Naropin
Naropin (TN)
NCGC00164597-01
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
ROPIVACAINE HCl
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
SAM001246524
SMR000469137
S-Ropivacaine
ST51051452
|
|
24 |
|
Clonidine |
Approved |
Phase 3 |
|
4205-90-7 |
2803 |
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
Adesipress
AKOS001595470
BIDD:GT0547
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
Boehringer ingelheim brand OF clonidine hydrochloride
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
C9H9Cl2N3
CAS-4205-91-8
Catapres
Catapres- TTS
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Catarpres-TTS (TN)
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
Chlofazoline
Chlophazolin
Chlornidinum
CID2803
Clofelin
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
clonidine
Clonidine
Clonidine (JAN/USAN/INN)
Clonidine [USAN:BAN:INN]
Clonidine dihydrochloride
Clonidine HCl
Clonidine hydrochloride
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
|
DB07566
Dihydrochloride, clonidine
DivK1c_000774
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
Hemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hydrochloride, clonidine
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
Lopac0_000268
Lopac-C-7897
LS-79606
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
Monohydrobromide, clonidine
Monohydrochloride, clonidine
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
nchembio.79-comp11
nchembio705-10
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
Spectrum_001341
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
ST 155BS
ST-155BS
ST-155-BS
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
|
|
25 |
|
Etodolac |
Approved, Investigational, Vet_approved |
Phase 3 |
|
41340-25-4 |
3308 |
Synonyms:
(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetate
(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(±)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetate
(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
[1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid
1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetate
1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetate
1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetate
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
110781-63-0 (mono-hydrochloride salt)
2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
41340-25-4
AB00052194
AC1L1FN2
AC-4231
Acid, etodolic
Acid, Etodolic
AY 24,236
AY 24236
AY24,236
AY-24,236
AY24236
AY-24236
BPBio1_000333
BRD-A74667430-001-05-3
BSPBio_000301
BSPBio_003138
CCRIS 3923
CHEBI:126431
CHEBI:4909
CHEMBL622
CID3308
CPD000058443
D00315
D017308
DB00749
DivK1c_000147
E 0516
E0516_SIGMA
Edolan
etodolac
Etodolac
Étodolac
Etodolac (JP15/USP/INN)
Etodolac [USAN:BAN:INN]
Etodolac [USAN:INN:BAN]
Etodolac, (-)-isomer
Etodolac, (+-)-isomer
Etodolac, (+-)-Isomer
Etodolac, (S)-isomer
Etodolac, monosodium salt
Etodolac, Monosodium Salt
Etodolac, monosodium salt, (+-) isomer
Etodolac, Monosodium Salt, (+-) Isomer
Etodolac, monosodium salt, (S)-isomer
Etodolac, Monosodium Salt, (S)-Isomer
|
Etodolacetodolic acid
Etodolaco
Etodolaco [INN-Spanish]
Etodolacum
Etodolacum [INN-Latin]
ETODOLate
Etodolic acid
ETODOLIC ACID
Etodolsäure
EU-0100479
HMS1568P03
HMS1921B09
HMS2092O20
HMS500H09
Hypen
IDI1_000147
KBio1_000147
KBio2_001724
KBio2_004292
KBio2_006860
KBio3_002358
KBioGR_000680
KBioSS_001724
Lodine
Lodine (TN)
Lodine SR
Lodine XL
Lopac0_000479
LS-7393
MLS000028474
MLS001077315
MolPort-001-759-084
NCGC00015399-04
NCGC00015399-11
NCGC00089769-02
NCGC00089769-03
NCGC00089769-04
NCGC00089769-05
NCGC00089769-06
NCGC00089769-07
NINDS_000147
NSC 282126
NSC282126
Osteluc
Prestwick_209
Prestwick0_000231
Prestwick1_000231
Prestwick2_000231
Prestwick3_000231
RAK-591
Ramodar
SAM002589968
SBB067257
SMR000058443
SPBio_001374
SPBio_002222
Spectrum_001244
SPECTRUM1501005
Spectrum2_001387
Spectrum3_001429
Spectrum4_000410
Spectrum5_001347
Ultradol
UNII-2M36281008
|
|
26 |
|
Ketamine |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
6740-88-1 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
100477-72-3
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
Calipsol
Calypsol
Cetamina
Cetamina [INN-Spanish]
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
DivK1c_000217
dl-Ketamine
|
DL-ketamine
DL-Ketamine
EINECS 229-804-1
Esketamine
Green
IDI1_000217
Kalipsol
KBio1_000217
Ketaject
Ketalar
Ketalar base
Ketamina
ketamine
Ketamine
Kétamine
Ketamine (INN)
Ketamine [INN:BAN]
Ketamine base
Ketamine Base
Ketamine HCL
KETAMINE HCL
Ketamine hydrochloride
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketaset
Ketoject
Ketolar
l-Ketamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
|
|
27 |
|
Glycolic acid |
Approved, Investigational |
Phase 3 |
|
79-14-1 |
757 |
Synonyms:
2-Hydroxyacetate
2-Hydroxyacetic acid
2-Hydroxyethanoate
2-Hydroxyethanoic acid
a-Hydroxyacetate
a-Hydroxyacetic acid
alpha-Hydroxyacetate
alpha-Hydroxyacetic acid
Glycocide
Glycolate
Glycolic acid, 1-(14)C-labeled
Glycolic acid, 2-(14)C-labeled
Glycolic acid, calcium salt
Glycolic acid, monoammonium salt
Glycolic acid, monolithium salt
Glycolic acid, monopotassium salt
|
Glycolic acid, monosodium salt
Glycolic acid, potassium salt
Glycollate
Glycollic acid
GlyPure
GlyPure 70
HOCH2COOH
Hydroxyacetate
Hydroxyacetic acid
Hydroxyethanoate
Hydroxyethanoic acid
Potassium glycolate
Sodium glycolate
Α-hydroxyacetate
α-hydroxyacetic acid
Α-hydroxyacetic acid
|
|
28 |
|
Ketoprofen |
Approved, Vet_approved |
Phase 3 |
|
22071-15-4 |
3825 |
Synonyms:
(+-)-3-Benzoyl-alpha-methylbenzeneacetic acid
(+-)-m-Benzoylhydratropic acid
154907-35-4
172964-50-0
19,583 RP
19583 RP
2-(3-Benzoylphenyl)propanoic acid
2-(3-Benzoylphenyl)propionate
2-(3-Benzoylphenyl)propionic acid
2-(m-Benzoylphenyl)propionic acid
2-[3-(benzoyl)phenyl]propanoic acid
2-[3-(phenylcarbonyl)phenyl]propanoic acid
2-[3-Benzoylphenyl]propionic acid
22071-15-4
22161-86-0
34016_FLUKA
34016_RIEDEL
3-Benzoyl-alpha-methylbenzeneacetate
3-Benzoyl-alpha-methylbenzeneacetic acid
3-BENZOYL-ALPHA-METHYLBENZENEACETIC ACID
3-Benzoyl-a-methylbenzeneacetate
3-Benzoyl-a-methylbenzeneacetic acid
3-Benzoylhydratropate
3-Benzoylhydratropic acid
3-Benzoyl-α-methylbenzeneacetate
3-Benzoyl-α-methylbenzeneacetic acid
AB00052249
AC-1486
AC1L1GST
AC1Q1LGA
Acide (benzoyl-3-phenyl)-2-propionique
Acide (benzoyl-3-phenyl)-2-propionique [French]
Actron
Alrheumat
Alrheumum
Alrheumun
Aneol
Benzoylhydratropic acid
Benzoylhydratropic Acid
BIDD:GT0443
BIM-0050664.0001
Bio-0742
BPBio1_000261
BRD-A97739905-001-05-9
BSPBio_000237
BSPBio_003037
C01716
Capisten
CCRIS 4508
CHEBI:6128
CHEMBL571
CID3825
CPD000040181
D00132
D007660
DB01009
Dexal
DivK1c_000598
EINECS 244-759-8
Epatec
EU-0100686
Fastum
FT-0082352
HMS1568L19
HMS1921B12
HMS2089B16
HMS2092L19
HMS501N20
I01-3439
IDI1_000598
InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)
Iso-K
K 1751
K0038
K1751_SIAL
K1751_SIGMA
K2012_SIAL
KBio1_000598
|
KBio2_001789
KBio2_004357
KBio2_006925
KBio3_002537
KBioGR_000435
KBioSS_001789
Kefenid
ketoprofen
Ketoprofen
Ketoprofen (+-)
Ketoprofen (JP15/USP/INN)
Ketoprofen [USAN:INN:BAN:JAN]
Ketoprofene
Ketoprofene [INN-French]
Ketoprofeno
Ketoprofeno [INN-Spanish]
Ketoprofenum
Ketoprofenum [INN-Latin]
Ketopron
Ketoprophene
L'acide (benzoyl-3-phenyl)-2-propionique
L'Acide (benzoyl-3-phenyl)-2-propionique
Lertus
Lopac0_000686
LS-28621
LS-7470
m-Benzoylhydratropate
m-Benzoylhydratropic acid
Menamin
Meprofen
MLS000028446
MLS000079024
MLS001201752
MLS001306444
MolPort-001-684-346
NCGC00015578-02
NCGC00015578-07
NCGC00094043-01
NCGC00094043-02
NCGC00094043-03
NCGC00094043-04
NINDS_000598
Oprea1_117113
Orudis
Orudis (TN)
Orudis KT
Orudis, Oruvail, Ketoflam, Orudis KT, Ketoprofen
Orugesic
Oruvail
Oscorel
Prestwick_617
Prestwick0_000219
Prestwick1_000219
Prestwick2_000219
Prestwick3_000219
Profenid
racemic-Ketoprofen
RP 19583
RP, 19,583
RP19583
RP-19583
RU 4733
S1645_Selleck
SAM002264620
SMR000040181
SPBio_000952
SPBio_002158
Spectrum_001309
SPECTRUM1501215
Spectrum2_000956
Spectrum3_001479
Spectrum4_000028
Spectrum5_001254
Toprec
Toprek
UNII-90Y4QC304K
UNM-0000306100
|
|
29 |
|
Manganese |
Approved, Nutraceutical |
Phase 3 |
|
7439-96-5 |
27854 |
Synonyms:
MANGANESE (II) ion
Manganese(II)
Manganese, ion (MN2+)
Manganous ion
|
|
|
30 |
|
Glutamic acid |
Approved, Nutraceutical |
Phase 2, Phase 3 |
|
56-86-0 |
33032 |
Synonyms:
(+)-Estrone
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-beta-D-Glucopyranosyl-beta-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(2R)-2,3-Dihydroxypropanoic acid
(2S)-2-Aminopentanedioate
(2S)-2-Aminopentanedioic acid
(3R,4S,5R)-5-[(1R)-1-Carboxy-2,2-difluoro-1-(phosphonooxy)ethoxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylate
(R)-2,3-Dihydroxypropanoic acid
(R)-Glycerate
(R)-Glyceric acid
(S)-(+)-Glutamate
(S)-(+)-Glutamic acid
(S)-2-Aminopentanedioate
(S)-2-Aminopentanedioic acid
(S)-Glutamate
(S)-Glutamic acid
09581_FLUKA
1,3,5(10)-Estratrien-3-ol-17-one
10549-13-0
138-15-8 (unspecified hydrochloride)
138-16-9
16690-92-9 (di-hydrochloride salt)
19238-49-4 (unspecified calcium salt)
19473-49-5 (mono-potassium salt)
1-Amino-2-hydroxyethane
1-Aminopropane-1,3-dicarboxylate
1-Amino-propane-1,3-dicarboxylate
1-Aminopropane-1,3-dicarboxylic acid
1-Amino-propane-1,3-dicarboxylic acid
1ftj
1ii5
1xff
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2 Aminoethanol
24595-14-0 (unspecified potassium salt)
24938-00-9
25513-46-6
26717-13-5
27322E29-9696-49C1-B541-86BEF72DE2F3
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
2-Amino-1-ethanol
2-Aminoethan-1-ol
2-Aminoethanol
2-Amino-ethanol
2-Aminoethyl alcohol
2-Aminoglutarate
2-Aminoglutaric acid
2-Aminopentanedioate
2-aminopentanedioic acid
2-Aminopentanedioic acid
2-Ethanolamine
2-Hydroxyethanamine
2-Hydroxyethylamine
3a,7a,12a-Trihydroxy-5b-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid-24-glycine
3alpha,7alpha,12alpha-Trihydroxy-N-(carboxymethyl)-5beta-cholan-24-amide
3-Hydroxy-1,3,5(10)-estratrien-17-one
3-Hydroxy-17-keto-estra-1,3,5-triene
3-Hydroxyestra-1,3,5(10)-trien-17-one
3-Hydroxyestra-1,3,5(10)-triene-17-one
3-Hydroxyoestra-1,3,5(10)-trien-17-one
3Α,7α,12α-trihydroxy-5β-cholan-24-oylglycine
3Α,7α,12α-trihydroxy-5β-cholanic acid-24-glycine
3Α,7α,12α-trihydroxy-N-(carboxymethyl)-5β-cholan-24-amide
49449_FLUKA
49449_SIGMA
55695-80-2 (mono-lithium salt)
56-86-0
6899-05-4
7558-63-6 (mono-ammonium salt)
84960-48-5
a,b-Hydroxypropionate
a,b-Hydroxypropionic acid
a-Aminoglutarate
a-Aminoglutaric acid
AB1002631
AC-11294
AC1L1OVN
AC1Q28OF
AC1Q4U8B
AC1Q4U8C
Acetylglucosamine
Acide glutamique
Acide glutamique [INN-French]
Acido glutamico
ácido glutámico
Acido glutamico [INN-Spanish]
Acidum glutamicum
Acidum glutamicum [INN-Latin]
Acidum glutaminicum
Aciglut
Aethanolamin
a-Glutamate
a-Glutamic acid
AI3-18472
alpha,beta-Hydroxypropionate
alpha,beta-Hydroxypropionic acid
alpha-Aminoglutarate
alpha-aminoglutaric acid
alpha-Aminoglutaric acid
alpha-Aminoglutaric acid (VAN)
alpha-Glutamate
alpha-Glutamic acid
alpha-L-Glutamic acid polymer
Aluminum L glutamate
Aluminum L-glutamate
AmbotzHAA1087
Aminoethanol
Aminoglutarate
Aminoglutaric acid
b-Aminoethanol
b-Aminoethyl alcohol
beta-Aminoethanol
beta-Aminoethyl alcohol
beta-Ethanolamine
beta-Hydroxyethylamine
b-Ethanolamine
b-Hydroxyethylamine
Biomol-NT_000170
BPBio1_001132
C00025
CCRIS 7314
CHEBI:16015
CHEMBL575060
Cholylglycine
CID33032
Colamine
D Glutamate
D00007
D1,3,5(10)-Estratrien-3-ol-17-one
D-2,3-Dihydroxypropanoic acid
DB00142
DB02517
D-GlcNAc
D-Glutamate
D-Glutamiensuur
D-Glycerate
D-Glyceric acid
D-GroA
|
E
E 620
EINECS 200-293-7
Envision conditioner PDD 9020
EPA Pesticide Chemical Code 374350
Estrone, (+-)-isomer
Estrone, (8 alpha)-isomer
Estrone, (9 beta)-isomer
Estrovarin
ETA
Ethylolamine
FEMA No. 3285
Follicular hormone
Folliculin
FT-0085107
G0059
G1251_SIGMA
G5667_SIGMA
G8415_SIGMA
Glt
glu
Glu
Glusate
glut
Glut
glutacid
Glutacid
glutamate
Glutamate
Glutamate, potassium
Glutamic acid
GLUTAMIC ACID
Glutamic acid (H-3)
Glutamic Acid (L-glutamic acid)
Glutamic acid (VAN)
Glutamic Acid [USAN:INN]
Glutamic acid polymer
Glutamic acid, (D)-isomer
Glutamic acid, L- (7CI,8CI)
Glutamic acid, L-, peptides
Glutamicol
Glutamidex
Glutaminate
glutaminic acid
Glutaminic acid
Glutaminic acid (VAN)
Glutaminol
Glutaton
Glycerate
Glycine cholate
Glycinol
Glycocholate
Glycocholate sodium
Glycocholic acid, sodium salt
Glycoreductodehydrocholic acid
Glycylcholate
Glycylcholic acid
Gulutamine
Gulutamine (USP)
Hauck brand OF estrone
Hea
H-Glu-OH
H-Glycinol
HSCI1_000269
Hyrex brand OF estrone
Kestrone
L Glutamate
L Glutamic acid
L-(+)-Glutamate
L-(+)-glutamic acid
L-(+)-Glutamic acid
L-2-Aminoglutaric acid
L-a-Aminoglutarate
L-a-Aminoglutaric acid
L-alpha-Aminoglutarate
L-alpha-Aminoglutaric acid
L-glu
L-Glu
L-glutamate
L-Glutamate
L-Glutamate, aluminum
L-glutamic acid
L-Glutamic acid
L-Glutamic acid (9CI)
L-Glutamic acid (JAN)
L-Glutamic acid hydrochloride
L-Glutamic acid, homopolymer
L-Glutamic acid, homopolymer (9CI)
L-Glutaminate
L-Glutaminic acid
L-Glutaminsaeure
Lopac0_000529
LS-2330
LS-71885
MEA
MolPort-001-770-254
Monoaethanolamin
MONOETHANOLAMINE
N Acetyl D glucosamine
N-(Carboxymethyl)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-amide
N-(Carboxymethyl)-3α,7α,12α-trihydroxy-5β-cholan-24-amide
N-[(3a,5b,7a,12a)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3Α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]glycine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
NCGC00024502-01
NCGC00024502-02
NCGC00024502-03
NCGC00024502-04
nchembio.186-comp9
nchembio.198-comp6
nchembio.2007.55-comp22
nchembio.266-comp23
nchembio.586-comp22
nchembio816-comp2
N-Choloylglycine
N-Choloyl-glycine
NSC 143503
Oestrone
Olamine
PDSP1_000128
PDSP1_001539
PDSP2_000127
PDSP2_001523
Poly(alpha-L-glutamic acid)
POLYGLUTAMIC ACID
Poly-L-glutamate
Potassium glutamate
R-Glycerate
R-Glyceric acid
Sodium Glutamate (L-glutamic Acid)
Tocris-0218
Unigen
UNII-3KX376GY7L
Vortech brand OF estrone
W328502_ALDRICH
Wehgen
Α,β-hydroxypropionate
Α,β-hydroxypropionic acid
Î’-aminoethanol
Î’-aminoethyl alcohol
Î’-ethanolamine
Î’-hydroxyethylamine
|
|
31 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
32 |
|
Copper Supplement |
|
Phase 3 |
|
|
|
33 |
|
Adrenergic alpha-Agonists |
|
Phase 3 |
|
|
|
34 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
35 |
|
Sympathomimetics |
|
Phase 3 |
|
|
|
36 |
|
Adrenergic Agonists |
|
Phase 3 |
|
|
|
37 |
|
Vasoconstrictor Agents |
|
Phase 3 |
|
|
|
38 |
|
Adrenergic beta-Agonists |
|
Phase 3 |
|
|
|
39 |
|
Sympatholytics |
|
Phase 3 |
|
|
|
40 |
|
Antihypertensive Agents |
|
Phase 3 |
|
|
|
41 |
|
Mydriatics |
|
Phase 3 |
|
|
|
42 |
|
Bronchodilator Agents |
|
Phase 3 |
|
|
|
43 |
|
Mitogens |
|
Phase 2, Phase 3 |
|
|
|
44 |
|
Neurotransmitter Agents |
|
Phase 2, Phase 3 |
|
|
|
45 |
|
Excitatory Amino Acid Antagonists |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Anesthetics, Intravenous |
|
Phase 2, Phase 3 |
|
|
|
47 |
|
Anesthetics, Dissociative |
|
Phase 2, Phase 3 |
|
|
|
48 |
|
Anesthetics, General |
|
Phase 2, Phase 3 |
|
|
|
49 |
|
Carboxymethylcellulose Sodium |
|
Phase 3 |
|
|
|
50 |
|
Calcium |
Nutraceutical |
Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
Interventional clinical trials:
(show top 50)
(show all 292)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Insertional Achilles Tendinopathy: A Randomized Trial to Evaluate the Effectiveness of Transferring the Flexor Hallucis Longus Tendon |
Unknown status |
NCT01341509 |
Phase 4 |
|
2 |
A Single-blinded Randomized Controlled Trial Comparing Patients Who Receive a Corticosteroid Injection for Nontraumatic Degenerative Rotator Cuff Tears or Tendinopathy and Scheduled Use of a Dynamic Elastic Garment to Patients Who Receive a Corticosteroid Injection Alone. |
Unknown status |
NCT03032432 |
Phase 4 |
Corticosteroid injection |
3 |
Functional Improvement and Ultrasound Tissue Characterisation of the Achilles Tendon Following Sodium Hyaluronate Injection for Plantaris Friction Syndrome |
Unknown status |
NCT03077009 |
Phase 4 |
Hyaluronic Acid |
4 |
The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial |
Completed |
NCT04743986 |
Phase 4 |
Corticosteroid (CS) |
5 |
Efficacy and Tolerance of Ultrasound-guided Needling and Lavage of Calcific Tendinitis of the Rotator Cuff Performed With or Without Subacromial Corticosteroid Injection: A Double Blind Controlled Study |
Completed |
NCT02403856 |
Phase 4 |
Sodium Chloride 0.9%;Methylprednisolone acetate |
6 |
Prospective Double-blind Randomized Clinical Trial Comparing Gait Analysis and Clinical Function After Metal on Metal Total Hip Arthroplasty With Large Diameter Femoral Head and Metal on Metal Total Hip Resurfacing. |
Completed |
NCT04516239 |
Phase 4 |
|
7 |
The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial |
Completed |
NCT00761423 |
Phase 4 |
|
8 |
Placebo Controlled Trial, Testing the Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles Tendinopathy. |
Completed |
NCT00377910 |
Phase 4 |
Aethoxysclerol |
9 |
The Value of a High-Volume Image-Guided Injection in Chronic Midportion Achilles Tendinopathy: a Double-blind, Randomized, Placebo-controlled Clinical Trial |
Completed |
NCT02996409 |
Phase 4 |
HVIGI;LVIGI |
10 |
Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to a Single Intrabursal Injection of Corticosteroids in Patients With Shoulder Calcific Tendinopathy |
Completed |
NCT01652495 |
Phase 4 |
methylprednisolone acetate;Triamcinolone Acetonide |
11 |
"NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes" |
Completed |
NCT00792376 |
Phase 4 |
etoricoxib;diclofenac |
12 |
Shockwave Therapy of Chronic Achilles Tendinopathy. A Double-blind, Randomized Clinical Trial of Efficacy |
Completed |
NCT00958620 |
Phase 4 |
|
13 |
Radiofrequency-based Plasma Microdebridement Compared to Surgical Microdebridement for Treating Achilles Tendinosis: A Prospective, Randomized, Controlled Multi-Center Study" |
Completed |
NCT00534781 |
Phase 4 |
|
14 |
Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer: A Prospective, Randomized, Controlled Trial |
Completed |
NCT00950053 |
Phase 4 |
|
15 |
A Prospective Study of the Use of the Madrid Ultrasound Scoring System in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis |
Completed |
NCT02960035 |
Phase 4 |
50mg etanercept;25mg etanercept;placebo |
16 |
Evaluation of Clinical Efficacy and Comparison of Autologous Platelet Rich Plasma, Hyaluronic Acid, Corticosteroid and Saline Injections for Treating Lateral and Medial Humeral Epicondylopathy |
Recruiting |
NCT04521387 |
Phase 4 |
Platelet Rich Plasma;Corticosteroid Injection;Hyaluronic Acid Injection |
17 |
Collagen and PRP in Partial Thickness Rotator Cuff Injuries: Friends or Only Indifferent Neighbors: Randomized Controlled Trial |
Recruiting |
NCT04492748 |
Phase 4 |
|
18 |
Betamethason Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis |
Active, not recruiting |
NCT02604537 |
Phase 4 |
betamethasone;Ketorolac |
19 |
Achilles Tendinopathy Treated With Heavy Slow Resistance Training Supplemented With Injection of Glucocorticosteroid or Local Anaesthetic. |
Active, not recruiting |
NCT02580630 |
Phase 4 |
Ultrasound guided injection with Glucocorticosteroid;Ultrasound guided injection with local anaestethic |
20 |
Comparative Effectiveness of Particulate Versus Nonparticulate Corticosteroid Injections for the Treatment of Musculoskeletal Conditions |
Not yet recruiting |
NCT04278833 |
Phase 4 |
Triamcinolone or Betamethasone;Dexamethasone |
21 |
Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection: A Randomized Controlled Double-Blind Study |
Not yet recruiting |
NCT04126278 |
Phase 4 |
Barbotage;Dexamethasone |
22 |
Comparison of Leukocyte-rich Platelet Rich Plasma Injection to Percutaneous Tenotomy in the Treatment of Chronic Common Extensor Tendinopathy |
Not yet recruiting |
NCT04384809 |
Phase 4 |
|
23 |
Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial |
Suspended |
NCT04115644 |
Phase 4 |
Ketorolac;Marcaine (placebo);Kenalog |
24 |
Ultrasound-Guided Platelet Rich Plasma Versus Whole Blood Injection for the Treatment of Gluteus Medius Tendinopathy: A Double-Blind Randomized Controlled Study |
Terminated |
NCT02978833 |
Phase 4 |
|
25 |
"Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis" |
Withdrawn |
NCT00420875 |
Phase 4 |
|
26 |
A Prospective Clinical Trial Comparing the Efficacy of Brisement to Physical Therapy for the Treatment of Achilles Tendinosis |
Withdrawn |
NCT03363789 |
Phase 4 |
|
27 |
A Randomized Single Blinded Prospective Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients |
Withdrawn |
NCT03319784 |
Phase 4 |
Ketorolac;Triamcinolone Acetonide |
28 |
Eccentric Training With Our Without Elbow Brace for Epicondylitis - a Randomized Clinical Trial |
Unknown status |
NCT01273688 |
Phase 3 |
|
29 |
Treatment of Subacromial Shoulder Pain |
Unknown status |
NCT01441830 |
Phase 3 |
|
30 |
Clinical Multicenter, Phase III, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ibuprofen 50mg/g Gel in the Treatment of Patients With Muscle Pain, Joint, or Pain Caused by Sprains, Contusions, Tendinitis, or Myofascial Compared to Profenid ® 25mg/g. Gel |
Unknown status |
NCT01373697 |
Phase 3 |
Ibuprofen;Profenid |
31 |
Treatment for Achilles Tendinopathy |
Unknown status |
NCT00835939 |
Phase 2, Phase 3 |
25% Dextrose and 1% Lidocaine;Lidocaine |
32 |
Multicenter, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety Aliviador Compared to Gelol in the Relief in Patients With Contusons, Sprains,Trauma and Muscle Injury. |
Unknown status |
NCT01097798 |
Phase 3 |
Aliviador;Gelol |
33 |
Vibration Training in Epicondylitis - a Randomized Trial |
Unknown status |
NCT01269879 |
Phase 3 |
|
34 |
A Randomized Clinical Trial Comparing the Effectiveness of Subacromial Decompression (Acromioplasty) Versus Subacromial Bursectomy (no Acromioplasty) in the Arthroscopic Treatment of Patients With Rotator Cuff Tendinosis |
Unknown status |
NCT00196573 |
Phase 3 |
|
35 |
Clinical Multicenter Study, Randomized, Open, to Evaluate the Efficacy and Safety of Salonsip Compared to Sabiá Plaster Relief of the Signs and Symptoms in Patients With Contusions, Sprains, Injuries and Muscular Injuries With Less Than 24 Hours Early or Holders of Myalgia, Pain and Tendonitis in Regions Miofasciais Articulated. |
Unknown status |
NCT00970658 |
Phase 3 |
Salonsip plaster;Sabia plaster |
36 |
Epidemiology of Incidents and Accidents in Sport. Influence of Moisture. |
Unknown status |
NCT02346786 |
Phase 3 |
|
37 |
Pilot Randomized Controlled Trial to Evaluate Safety and Efficacy of Percutaneous Needle Tenotomy With Platelet Rich Plasma (Leukocyte Depleted)in Epicondylitis |
Completed |
NCT01945528 |
Phase 3 |
US-guided tenotomy with PRP;US-guided tenotomy with lidocaine |
38 |
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Pain Due to Mild to Moderate Tendonitis or Bursitis |
Completed |
NCT00640939 |
Phase 2, Phase 3 |
diclofenac sodium;Matching Placebo |
39 |
URINARY INCONTINENCE AND URO-GENITAL PROLAPSE: A RANDOMIZED TRIAL OF PELVIC ORGAN PROLAPSE REPAIR PLUS MINI-SLING VERSUS PELVIC ORGAN PROLAPSE REPAIR ALONE |
Completed |
NCT01384084 |
Phase 3 |
|
40 |
The Value of Autologous Tenocyte Implantation in Patients With Chronic Achilles Tendinopathy: a Double-blind Randomised Clinical Trial |
Completed |
NCT01343836 |
Phase 2, Phase 3 |
|
41 |
Role of Biological Therapy in Rotator Cuff Tendinopathy. Effectiveness of Plasma Rich in Growth Factors Regarding Functional Capacity and Pain Compared With the Conventional Treatment Using Steroids |
Completed |
NCT01915979 |
Phase 3 |
Celestone cronodose (Bethametasone) |
42 |
Impact of Peripheral Pain Perception on Central Sensitization and Movement Strategies in Patients With Chronic Achilles Tendinopathy |
Completed |
NCT03316378 |
Phase 2, Phase 3 |
Ropivacaine injection |
43 |
Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery |
Completed |
NCT02741713 |
Phase 3 |
Solution for Injection in Interscalene Block;Solution for Injection in Sham Block;Solution for Injection PECS Blocks |
44 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee |
Completed |
NCT00352625 |
Phase 3 |
Ketoprofen Topical Patch 20% |
45 |
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder |
Completed |
NCT01161615 |
Phase 3 |
MRX-7EAT;Placebo |
46 |
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Topical Patch in the Treatment of Pain Due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of Shoulder |
Completed |
NCT01506154 |
Phase 3 |
MRX-7EAT |
47 |
Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy? |
Recruiting |
NCT02967640 |
Phase 2, Phase 3 |
Ketalar;NaCl 9% |
48 |
Great Trochanteric Pain Syndrome: Parallel Group, Blind Randomised Clinical Trial to Assess the Efficacy and Safety of PRP Injection Versus Needle Tenotomy With Lidocaine |
Recruiting |
NCT04231357 |
Phase 3 |
platelet rich plasma |
49 |
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease |
Recruiting |
NCT04094298 |
Phase 3 |
FX006 Injection |
50 |
Evaluation of Regenerative Medicine Treatment Outcomes With Amniotic Fluid for Musculoskeletal Conditions |
Recruiting |
NCT03390920 |
Phase 2, Phase 3 |
|
Cochrane evidence based reviews: tendinopathy
|